Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:09:06.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record. This blocks access to the usual study details and navigation.
    Difference
    0.5%
    Check dated 2026-09-27T16:42:32.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page instead of the study details, with a simple header and a Home link, plus a revision tag indicating an update.
    Difference
    18%
    Check dated 2026-09-20T11:21:02.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The MedlinePlus related topics section now includes entries for 'Ovarian cancer' and 'MedlinePlus Genetics', expanding the disease context and linked genetics resources.
    Difference
    0.2%
    Check dated 2026-09-13T02:11:49.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Removal of the ovarian cancer term and a linked genetics resource from the page's related topics section. This affects topic tagging and cross-references, potentially impacting discoverability for ovarian cancer content.
    Difference
    0.2%
    Check dated 2026-09-06T00:26:15.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Adds NIH grant/contract note (2018), mentions ovarian cancer and related topics (MedlinePlus Genetics), and updates the site revision to v3.6.6 to reflect a newer release.
    Difference
    0.3%
    Check dated 2026-08-29T23:48:43.000Z thumbnail image

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.